These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2706010)

  • 41. Inhibition by warfarin of liver microsomal vitamin K-reductase in warfarin-resistant and susceptible rats.
    MacNicoll AD; Nadian AK; Townsend MG
    Biochem Pharmacol; 1984 Apr; 33(8):1331-6. PubMed ID: 6712738
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of the rat liver microsomal metabolism of the enantiomers of warfarin and 4'-nitrowarfarin (acenocoumarol).
    Hermans JJ; Thijssen HH
    Xenobiotica; 1991 Mar; 21(3):295-307. PubMed ID: 1862655
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vitamin K epoxide reductase activity in the metabolism of epoxides.
    Liptay-Reuter I; Dose K; Guenthner T; Wörner W; Oesch F
    Biochem Pharmacol; 1985 Aug; 34(15):2617-20. PubMed ID: 4015704
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assembly of the warfarin-sensitive vitamin K 2,3-epoxide reductase enzyme complex in the endoplasmic reticulum membrane.
    Cain D; Hutson SM; Wallin R
    J Biol Chem; 1997 Nov; 272(46):29068-75. PubMed ID: 9360981
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of N-ethylmaleimide on beef and rat liver vitamin K1 epoxide reductase.
    Silverman RB; Nandi DL
    J Enzyme Inhib; 1990; 3(4):289-94. PubMed ID: 2319331
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is thioredoxin the physiological vitamin K epoxide reducing agent?
    Preusch PC
    FEBS Lett; 1992 Jul; 305(3):257-9. PubMed ID: 1299627
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and structure-activity relationships of novel warfarin derivatives.
    Gebauer M
    Bioorg Med Chem; 2007 Mar; 15(6):2414-20. PubMed ID: 17275317
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The potent antioxidant activity of the vitamin K cycle in microsomal lipid peroxidation.
    Vervoort LM; Ronden JE; Thijssen HH
    Biochem Pharmacol; 1997 Oct; 54(8):871-6. PubMed ID: 9354587
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rat and human liver vitamin K epoxide reductase: inhibition by thiol blockers and vitamin K1.
    Wallin R; Patrick SD; Martin LF
    Int J Biochem; 1987; 19(11):1063-8. PubMed ID: 3428478
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Heterogeneity of the coumarin anticoagulant targeted vitamin K epoxide reduction system. Study of kinetic parameters in susceptible and resistant mice (Mus musculus domesticus).
    Lasseur R; Grandemange A; Longin-Sauvageon C; Berny P; Benoit E
    J Biochem Mol Toxicol; 2006; 20(5):221-9. PubMed ID: 17009238
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Warfarin poisoning and vitamin K antagonism in rat and human liver. Design of a system in vitro that mimics the situation in vivo.
    Wallin R; Martin LF
    Biochem J; 1987 Jan; 241(2):389-96. PubMed ID: 3593198
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanism of coumarin action: significance of vitamin K epoxide reductase inhibition.
    Whitlon DS; Sadowski JA; Suttie JW
    Biochemistry; 1978 Apr; 17(8):1371-7. PubMed ID: 646989
    [No Abstract]   [Full Text] [Related]  

  • 53. Relationship of dithiothreitol-dependent microsomal vitamin K quinone and vitamin K epoxide reductases inhibition of epoxide reduction by vitamin K quinone.
    Preusch PC; Suttie JW
    Biochim Biophys Acta; 1984 Mar; 798(1):141-3. PubMed ID: 6704420
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vitamin K1 hydroquinone formation catalyzed by a microsomal reductase system.
    Fasco MJ; Principe LM
    Biochem Biophys Res Commun; 1980 Dec; 97(4):1487-92. PubMed ID: 7213374
    [No Abstract]   [Full Text] [Related]  

  • 55. Normal and warfarin-resistant rat hepatocyte metabolism of vitamin K 2,3-epoxide: evidence for multiple pathways of hydroxyvitamin K formation.
    Trivedi LS; Rhee M; Galivan JH; Fasco MJ
    Arch Biochem Biophys; 1988 Jul; 264(1):67-73. PubMed ID: 3395132
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vitamin K-dependent carboxylation and vitamin K metabolism in liver. Effects of warfarin.
    Wallin R; Martin LF
    J Clin Invest; 1985 Nov; 76(5):1879-84. PubMed ID: 3932474
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Indirect inhibition of vitamin K epoxide reduction by salicylate.
    Hildebrandt E; Suttie JW
    J Pharm Pharmacol; 1984 Sep; 36(9):586-91. PubMed ID: 6149281
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Substituted vitamin K epoxide analogues. New competitive inhibitors and substrates of vitamin K1 epoxide reductase.
    Ryall RP; Nandi DL; Silverman RB
    J Med Chem; 1990 Jun; 33(6):1790-7. PubMed ID: 2342073
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of microsomal drug-metabolizing enzymes from rat liver by various 4-hydroxycoumarin derivatives.
    Christensen F; Wissing F
    Biochem Pharmacol; 1972 Apr; 21(7):975-84. PubMed ID: 4114280
    [No Abstract]   [Full Text] [Related]  

  • 60. 2-(Fluoromethyl)-3-phytyl-1,4-naphthoquinone and its 2,3-epoxide. Inhibition of vitamin K epoxide reductase.
    Silverman RB; Oliver JS
    J Med Chem; 1989 Sep; 32(9):2138-41. PubMed ID: 2769684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.